Evidence map›Paper›PMID 34660313›Full record

ArticleFrontiers in oncology2021

Jipeng Yin, Bo Xin, Mingru Zhang, Xiaoli Hui, Na Chai, Hao Hu, Bing Xu, Jing Wang, Yongzhan Nie, Guangqing Zhou and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Advances in nanomedicine and delivery systems for gastric cancer research.Frontiers in bioengineering and biotechnology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Jipeng YinSchool of Biomedical Engineering, Fourth Military Medical University, Xi'an, China.
Bo XinDepartment of Oncology, No. 960 Hospital of PLA, Taian, China.
Mingru ZhangDepartment of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Xiaoli HuiFirst Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Na ChaiState Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China.
Hao HuState Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China.
Bing XuState Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China.
Jing WangDepartment of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Yongzhan NieState Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China.
Guangqing ZhouClinical Medical Research Center, The 75th Group Army Hospital of Chinese People's Liberation Army (PLA), Dali, China.
Guanliang WangClinical Medical Research Center, The 75th Group Army Hospital of Chinese People's Liberation Army (PLA), Dali, China.
Hongbing LuSchool of Biomedical Engineering, Fourth Military Medical University, Xi'an, China.
Liping YaoState Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China.
Liusheng ChenClinical Medical Research Center, The 75th Group Army Hospital of Chinese People's Liberation Army (PLA), Dali, China.
Kaichun WuState Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China.
Air Force Medical University · CNXijing Hospital · CNChinese People's Liberation Army · CNFirst Affiliated Hospital of Xi'an Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo synthesize the dimer of GX1 and identify whether its affinity and targeting are better than those of GX1. To prepare

methods

results

conclusionGX1 was modified successfully, and the

Indexed as

Cerenkov imaginggastric cancerGX1 dimerPET imagingTGM2

Identifiers

PMID34660313
PMCPMC8514943
OpenAlexW3203195917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.